Skip to main content

Clinical Services

Our team has a proven track record of successfully delivering medicinal products to the market. We support companies in regulatory strategy together with all aspects relevant for a timely preclinical/clinical development of NCE, biologics, biosimilars and medical devices.

Scientific due diligence, gap analysis and exit preparation will be supported from a seller or buyer perspective.

    Our general clinical services cover

  • Gap analysis for drug development, scientific drug evaluation
  • Assessment of company development structures, benchmark comparison
  • Portfolio management, in-/out-licensing
  • Clinical development strategy and planning
  • Regulatory compliance
  • Quality Risk Management
  • Medical information
  • Pharmacovigilance
  • Orphan drug – rare disease
  • Repurposing, relabelling
  • Interim Management Chief Medical Officer, Change processes, Project management
back